Medicaid Expansion and Stage-Specific Colorectal Cancer Survival
The American Surgeon™ · 2026
DOI: 10.1177/00031348261465402 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, 2026. Verfasst von Oluwasegun Akinyemi und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Clive O. Callender Outcomes Research Center, Department of Surgery, Howard University College of Medicine, Washington, DC, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Medicaid, Patient Protection and Affordable Care Act. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Medicaid expansion under the Affordable Care Act has been associated with improved colorectal cancer (CRC) outcomes, predominantly attributed to earlier diagnosis and stage migration. However, it remains unclear whether survival benefits vary across disease stages.
Objective
To evaluate cancer-specific survival (CSS) after Medicaid expansion across disease stages among working-age adults with CRC, comparing the expansion state of California with the non-expansion state of Texas.
Methods
We conducted a retrospective cohort study using Surveillance, Epidemiology, and End Results (SEER) registry data (2007-2021) for patients aged 18-64 years with primary CRC. A difference-in-differences design compared pre-ACA (2007-2013) and post-ACA (2015-2021) periods between California and Texas. CSS was modeled using Cox proportional hazards regression adjusting for demographics, tumor characteristics, and treatments. Analyses were stratified by disease stage (localized, regional, distant) and race/ethnicity.
Results
Among 122,543 patients, CSS improved after Medicaid expansion in California relative to Texas. Stage-stratified difference-in-differences models showed a modest reduction in cancer-specific mortality for localized disease 0.985 (0.974-0.996), a larger reduction for regional disease 0.941 (0.900-0.983), and the greatest reduction for distant metastatic disease 0.689 (0.525-0.903). Improvements were consistent across racial/ethnic groups, with the largest relative reduction among non-Hispanic Black patients 0.855 (0.763-0.958).
Conclusion
Medicaid expansion was associated with stage-dependent improvements in CRC survival, with the most pronounced benefit for patients with metastatic disease. These findings suggest that enhanced access to systemic therapy, multidisciplinary care, and financial protection may yield survival gains beyond those mediated by stage shift alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Clive O. Callender Outcomes Research Center, Department of Surgery, Howard University College of Medicine, Washington, DC, USA.
- Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
ORCID-Profile: Kaelyn Gordon
Zitieren
APA
Akinyemi, O., Gordon, K., Fasokun, M., Nnorom, S., Cornwell, E., Hughes, K., & Nembhard, C. (2026). Medicaid Expansion and Stage-Specific Colorectal Cancer Survival. The American Surgeon™. https://doi.org/10.1177/00031348261465402
Vancouver
Akinyemi O, Gordon K, Fasokun M, Nnorom S, Cornwell E, Hughes K, et al. Medicaid Expansion and Stage-Specific Colorectal Cancer Survival. The American Surgeon™. 2026. doi:10.1177/00031348261465402
BibTeX
@article{Akinyemi2026,
author = {Akinyemi, Oluwasegun and Gordon, Kaelyn and Fasokun, Mojisola and Nnorom, Siobhan and Cornwell, Edward and Hughes, Kakra and Nembhard, Christine},
title = {Medicaid Expansion and Stage-Specific Colorectal Cancer Survival},
journal = {The American Surgeon™},
year = {2026},
doi = {10.1177/00031348261465402}
}
EUVIMED